Silencing of mutant p53 by siRNA induces cell cycle arrest and apoptosis in human bladder cancer cells
about
Targeting Oncogenic Mutant p53 for Cancer TherapyMolecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancerp53 as a Regulator of Lipid Metabolism in CancerArsenic trioxide reactivates proteasome-dependent degradation of mutant p53 protein in cancer cells in part via enhanced expression of Pirh2 E3 ligasemiR-600 inhibits cell proliferation, migration and invasion by targeting p53 in mutant p53-expressing human colorectal cancer cell lines.Elevated p53 expression levels correlate with tumor progression and poor prognosis in patients exhibiting esophageal squamous cell carcinoma.Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells.Trans-splicing repair of mutant p53 suppresses the growth of hepatocellular carcinoma cells in vitro and in vivo.Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities.The impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis.Mechanisms of radiation toxicity in transformed and non-transformed cellsDepletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63.Mutant p53 in cancer: new functions and therapeutic opportunities.TPX2-p53-GLIPR1 regulatory circuitry in cell proliferation, invasion and tumor growth of bladder cancer.ATM mediates DAB2IP-deficient bladder cancer cell resistance to ionizing radiation through the p38MAPK and NF-κB signaling pathway.P53 codon 72 Arg/Pro polymorphism and glioma risk: an updated meta-analysis.High expression of TMEM40 is associated with the malignant behavior and tumorigenesis in bladder cancer.
P2860
Q26770856-441B3A15-630E-4769-BDA1-C2C687AB674AQ28076041-64DA6E96-A51E-4B7D-858A-8A5BBC6A8E2BQ28079393-C0B02564-663C-4DCC-8D12-415DEC7C611AQ28541801-80A8BB7A-E926-4F18-B74E-D21E42D0740EQ33599315-BFF90D2D-0486-41DF-81BB-1F390D5A5816Q34141638-1F682850-6B43-4955-9AF5-4AEA83924B8DQ35040623-9B1FE072-1B1F-468A-AF3B-3A2CF95E840EQ35138721-481997C8-3790-4A29-82BD-3FDAE6A13A3EQ36905671-2A128BD0-D420-4F3F-84F2-0D8671BFD424Q37031974-0FCEFC90-93E5-4FA0-955A-516809AE5756Q37139115-E2D8872A-D7CA-494C-B84B-AD0921EDDCAFQ37687744-932EACBF-2896-41C6-821B-0BB221BAC50AQ38197826-DB91CABB-214F-4B31-A9A9-0B914E3B8BF8Q38629126-170BCF49-BB8E-40A0-9C28-8D7C4E83CA45Q38741043-583CA08A-F628-4026-9C0E-B5292D30DD08Q44176695-35341116-2217-400F-885E-CA7A5740F605Q49286589-4AE77F68-4341-4187-908F-B52AB0E0C27F
P2860
Silencing of mutant p53 by siRNA induces cell cycle arrest and apoptosis in human bladder cancer cells
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Silencing of mutant p53 by siR ...... in human bladder cancer cells
@ast
Silencing of mutant p53 by siR ...... in human bladder cancer cells
@en
type
label
Silencing of mutant p53 by siR ...... in human bladder cancer cells
@ast
Silencing of mutant p53 by siR ...... in human bladder cancer cells
@en
prefLabel
Silencing of mutant p53 by siR ...... in human bladder cancer cells
@ast
Silencing of mutant p53 by siR ...... in human bladder cancer cells
@en
P2093
P2860
P356
P1476
Silencing of mutant p53 by siR ...... in human bladder cancer cells
@en
P2093
Hai-Bin Zhu
Li-Ping Xie
Yan-Qi Xie
Yi-Wei Lin
P2860
P2888
P356
10.1186/1477-7819-11-22
P577
2013-01-28T00:00:00Z
P5875
P6179
1033920907